PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för avibactam. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

20 hits

Bibliografisk träff 2015-05-29

Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.

Singh R, Kim A, Tanudra MA, Harris JJ, McLaughlin RE, Patey S, O'Donnell JP, Bradford PA, Eakin AE.

J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkv132

Bibliografisk träff 2015-05-18

Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota.

Rashid MU, Rosenborg S, Panagiotidis G, Söderberg-Löfdal K, Weintraub A, Nord CE.

Antimicrob Agents Chemother · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00530-15

Bibliografisk träff 2015-05-11

In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.

Biedenbach DJ, Kazmierczak K, Bouchillon SK, Sahm DF, Bradford PA.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00206-15

Bibliografisk träff 2015-05-08

Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.

Winkler ML, Papp-Wallace KM, Bonomo RA.

J Antimicrob Chemother · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1093/jac/dkv094

Bibliografisk träff 2015-05-01

Safety and pharmacokinetics of single and multiple ascending doses of avibactam alone and in combination with ceftazidime in healthy male volunteers: results of two randomized, placebo-controlled studies.

Merdjan H, Rangaraju M, Tarral A.

Clin Drug Investig · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1007/s40261-015-0283-9

Bibliografisk träff 2015-04-20

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.

Rashid MU, Rosenborg S, Panagiotidis G, Löfdal KS, Weintraub A, Nord CE.

Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2015.02.027

Bibliografisk träff 2015-04-06

Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.

Sader HS, Castanheira M, Mendes RE, Flamm RK, Farrell DJ, Jones RN.

Antimicrob Agents Chemother · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1128/aac.05024-14

Bibliografisk träff 2015-04-06

Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.

Castanheira M, Mills JC, Costello SE, Jones RN, Sader HS.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00163-15

Bibliografisk träff 2015-03-09

Activity of ceftazidime-avibactam against fluoroquinolone-resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Pitart C, Marco F, Keating TA, Nichols WW, Vila J.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.05136-14

Bibliografisk träff 2015-02-17

Avibactam and inhibitor-resistant SHV β-lactamases.

Winkler ML, Papp-Wallace KM, Taracila MA, Bonomo RA.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.04405-14

Bibliografisk träff 2015-02-17

In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.

Testa R, Cantón R, Giani T, Morosini MI, Nichols WW, Seifert H, Stefanik D, Rossolini GM, Nordmann P.

Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2014.12.033

Bibliografisk träff 2015-02-14

Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

Papp-Wallace KM, Bajaksouzian S, Abdelhamed AM, Foster AN, Winkler ML, Gatta JA, Nichols WW, Testa R, Bonomo RA, Jacobs MR.

Diagn Microbiol Infect Dis · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.diagmicrobio.2015.02.003

Bibliografisk träff 2015-02-09

Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.

Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA.

Bibliografisk träff 2015-02-02

Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.

Berkhout J, Melchers MJ, van Mil AC, Seyedmousavi S, Lagarde CM, Nichols WW, Mouton JW.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04627-14

Bibliografisk träff 2015-01-12

In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.

Levasseur P, Girard AM, Miossec C, Pace J, Coleman K.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04218-14

Bibliografisk träff 2014-12-22

In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.

Li H, Estabrook M, Jacoby GA, Nichols WW, Testa RT, Bush K.

Antimicrob Agents Chemother · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1128/aac.04191-14

Bibliografisk träff 2014-12-08

In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays.

Berkhout J, Melchers MJ, van Mil AC, Nichols WW, Mouton JW.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04146-14

Bibliografisk träff 2014-12-04

Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.

Lahiri SD, Mangani S, Jahić H, Benvenuti M, Durand-Reville TF, De Luca F, Ehmann DE, Rossolini GM, Alm RA, Docquier JD.

ACS Chem Biol · research support, non-u.s. gov't; journal article · DOI 10.1021/cb500703p

Bibliografisk träff 2014-10-31

β-lactam/β-lactamase inhibitor combinations: from then to now.

Toussaint KA, Gallagher JC.

Ann Pharmacother · review; journal article · DOI 10.1177/1060028014556652

Bibliografisk träff 2014-10-25

In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.

Yoshizumi A, Ishii Y, Aoki K, Testa R, Nichols WW, Tateda K.

J Infect Chemother · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jiac.2014.08.028